A detailed history of Quantbot Technologies LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quantbot Technologies LP holds 25,387 shares of BMY stock, worth $1.43 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
25,387
Previous 185,904 86.34%
Holding current value
$1.43 Million
Previous $7.72 Million 82.99%
% of portfolio
0.06%
Previous 0.39%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $6.37 Million - $8.31 Million
-160,517 Reduced 86.34%
25,387 $1.31 Million
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $7.48 Million - $9.85 Million
185,904 New
185,904 $7.72 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $1.54 Million - $1.84 Million
31,818 Added 41.79%
107,951 $5.54 Million
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $2.87 Million - $3.21 Million
49,609 Added 187.03%
76,133 $4.42 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $778,727 - $864,655
12,223 Added 85.47%
26,524 $1.7 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $3.31 Million - $3.75 Million
-50,348 Reduced 77.88%
14,301 $991,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $4.43 Million - $5.24 Million
64,649 New
64,649 $4.65 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $849,223 - $1.02 Million
-13,813 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $498,008 - $580,560
-9,286 Reduced 40.2%
13,813 $861,000
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $1.37 Million - $1.6 Million
23,099 New
23,099 $1.37 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $11.9 Million - $13 Million
-192,650 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $8.2 Million - $9.22 Million
138,145 Added 253.45%
192,650 $12.2 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $4.94 Million - $5.59 Million
-85,471 Reduced 61.06%
54,505 $3.38 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $8.04 Million - $8.91 Million
139,976 New
139,976 $8.44 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $534,626 - $637,476
-11,849 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $2.28 Million - $2.96 Million
-46,789 Reduced 79.79%
11,849 $615,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $714,158 - $805,515
-12,940 Reduced 18.08%
58,638 $3.64 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $2.45 Million - $3.05 Million
48,424 Added 209.14%
71,578 $3.96 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $908,806 - $1.05 Million
15,167 Added 189.9%
23,154 $1.46 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $336,263 - $366,613
5,610 Added 236.01%
7,987 $489,000
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $131,281 - $151,509
2,377
2,377 $151,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.